NCT05278975
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05278975
Title Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors RS Oncology LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries GBR

Facility Status City State Zip Country Details
South Mead North Bristol Hopsital Bristol Bristol BS105NB United Kingdom Details
Leeds Teaching Hospital Leeds Leeds LS970F United Kingdom Details
Northumbria NorthTyne Side General Hospital North Shields North Shields NE29 8NH United Kingdom Details
NHS Greater Glasgow & Clyde Glasgow United Kingdom Details
Facility: HOPE Clinical Trials Facility, Leicester Royal Infirmary Leicester LE1 5WW United Kingdom Details
Barts Health NHS Cancer Institute London EC1A7BE United Kingdom Details
Guys and St Thomas NHS Foundation Trust London SE19RT United Kingdom Details
The Royal Marsden London SW3 6JJ United Kingdom Details
The Christie NHS Manchester M204BX United Kingdom Details
Oxford University Hospitals NHS Foundation Oxford OX42PG United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field